Kiniksa Pharmaceuticals International Newsroom

Earnings Preview: KNSA to Report Financial Results Pre-market on October 29

$Kiniksa Pharmaceuticals International(KNSA.US)$ is scheduled to release its financial results pre-market on October 29 ET. Earnings PreviewAnalysts estimate $Kiniksa Pharmaceuticals International(

Futu NewsOct 23 19:45

Press Release: Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024

Dow JonesOct 23 04:01

Wells Fargo Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Maintains Target Price $35

Futu NewsOct 10 20:36 · Ratings

Wall Street Analysts Think Kiniksa Pharmaceuticals (KNSA) Could Surge 42.34%: Read This Before Placing a Bet

Zacks Oct 9 21:05

Express News | Kiniksa Pharmaceuticals Ltd: Board Size Increases From Nine to Ten

BreakingsOct 8 04:36

Kiniksa Pharmaceuticals International Insider Sold Shares Worth $437,325, According to a Recent SEC Filing

MT NewswiresSep 26 04:42

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Delivers Shareholders Stellar 23% CAGR Over 5 Years, Surging 4.7% in the Last Week Alone

Simply Wall StSep 17 22:12

Kiniksa Draws Buy at Jefferies on Potential Blockbuster Status for Lead Drug

Seeking AlphaSep 13 23:20

Jefferies Initiates Kiniksa Pharmaceuticals at Buy With $40 Price Target

MT NewswiresSep 13 19:38 · Ratings

Jefferies Initiates Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Announces Target Price $40

Jefferies analyst Roger Song initiates coverage on $Kiniksa Pharmaceuticals International(KNSA.US)$ with a buy rating, and sets the target price at $40.According to TipRanks data, the analyst has a

Futu NewsSep 13 17:33 · Ratings

J.P. Morgan Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $39

J.P. Morgan analyst Anupam Rama maintains $Kiniksa Pharmaceuticals International(KNSA.US)$ with a buy rating, and adjusts the target price from $38 to $39.According to TipRanks data, the analyst has

Futu NewsSep 12 20:32 · Ratings

Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference

newsfilter.ioAug 29 04:01

Roth MKM Says Small-Cap Value Reaches Key Technical Support, Lists 14 "Bullish" Stocks

Seeking AlphaAug 12 23:34

New Strong Buy Stocks for August 1st

Zacks Aug 1 18:25

Express News | Kiniksa Pharmaceuticals Ltd : JP Morgan Raises Target Price to $38 From $30

BreakingsAug 1 13:34

Kiniksa Pharmaceuticals International Insider Sold Shares Worth $578,966, According to a Recent SEC Filing

MT NewswiresJul 26 20:34

Kiniksa Pharmaceuticals International(KNSA.US) Officer Sells US$3.49 Million in Common Stock

$Kiniksa Pharmaceuticals International(KNSA.US)$ Officer Patel Sanj K sold 136.12K shares of common stock on Jul 23, 2024 at an average price of $25.65 for a total value of $3.49 million.Source:

Futu NewsJul 26 04:36

Kiniksa Pharmaceuticals International | 10-Q: Q2 2024 Earnings Report

SECJul 26 04:16 · Announcements

Kiniksa Pharmaceuticals International And Two More Firms Possibly Priced Below Market Value Estimates

Yahoo FinanceJul 24 21:07

There's No Escaping Kiniksa Pharmaceuticals International, Plc's (NASDAQ:KNSA) Muted Revenues Despite A 41% Share Price Rise

Simply Wall StJul 24 20:47